BREEMAX FORTE LIFE CAPS
MRP: 393
Packaging: 30 Caps
Pack Type: life-caps
Composition:
Budesonide 400 mcg + Formoterol Fumarate Dihydrate 12 mcg
Indication:
Reduction in incidence of exacerbation and asthma, More rapid onset of action than Salmeterol/Fluticasone
Description:
This combination inhaler of Budesonide 400 mcg and Formoterol Fumarate Dihydrate 12 mcg is a dual-action respiratory therapy designed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). Budesonide is a corticosteroid that reduces airway inflammation, while Formoterol is a long-acting β2-agonist (LABA) that relaxes bronchial muscles to ensure easy breathing and prolonged bronchodilation. Together, they prevent asthma attacks, reduce wheezing, and improve overall lung function when used regularly.
Tags:
- Reduces airway inflammation and tightness
- Provides long-acting bronchodilation (up to 12 hours)
- Improves breathing and exercise tolerance
- Lowers risk of asthma/COPD exacerbations
- Convenient once or twice daily use
Usage Information
Dosage
Adults and adolescents (>12 years): Typically 1 inhalation twice daily (morning and evening) or as directed Do not exceed prescribed dose Rinse mouth with water after use to avoid oral thrush Use a spacer device if recommended
Side Effects
Hoarseness, sore throat Oral thrush (fungal infection in mouth) Headache, nausea Muscle cramps, tremors Palpitations or chest discomfort (rare)
Contraindications
Allergy to budesonide, formoterol, or any component Not for acute bronchospasm relief Use with caution in heart conditions, diabetes, or seizure disorders Avoid abrupt discontinuation without medical advice
Availability
budesonide formoterol inhaler budesonide 400 mcg DPI formoterol 12 mcg asthma medicine COPD maintenance inhaler dual therapy asthma treatment anti-inflammatory inhaler budesonide formoterol for wheezing long-term asthma control steroid LABA combination inhaler prevent asthma attacks